Category Archives: INCELL News
An exciting new strategic partnership was announced between INCELL and Charter Medical Ltd, to globally distribute INCELL’s innovative specialty and cell therapy media and formulated solutions for tissue and cell collection, transport, processing and storage. This partnership will enable both organizations to meet the growing customer demand for more comprehensive solutions in cell and tissue therapies, cell culture, […]
Mary Pat Moyer was an invited speaker at the American Association of Orthopaedic Medicine’s 34th Annual Conference and Scientific Seminar, titled Regenerative Orthopedic Medicine: Integration in Evolution, in Seattle Washington, April 19-22. Her presentation, entitled “Helping Doctors Make Science-Based Decisions about Marketed Regenerative Medicine Products,” was well-received and generated much discussion.
December 12, 2016 – San Antonio TX USA- In an article by W. Scott Bailey published today, the San Antonio Business Journal has featured INCELL as an example of collaborative global economic opportunities with Belgium. The article quoted Ann Stevens, president of BioMed SA, who noted that last week’s visit to the Alamo City by an international delegation including […]
December 9, 2016 – San Antonio, TX USA. INCELL and the BIOTURNKEY Initiative, our joint venture partner in Belgium, co-sponsored a booth at the 12th Annual World Stem Cell Summit in West Palm Beach, FL on December 6-9, 2016. This kicked off partnering INCELL’s GMP products and platforms with the BIOTURNKEY business model on accelerating GMP global […]

October 27, 2016 – San Antonio, TX USA. INCELL and the BIOTURNKEY Initiative, our joint venture partner in Belgium, will co-sponsor a booth at the 12th Annual World Stem Cell Summit in West Palm Beach, FL on December 6-9, 2016. This kicks off a new initiative on accelerating GMP and closed system manufacturing. Visit us at Booth […]

March 1-6, 2016 – Belgium. As CEO of INCELL, 4RMED and TEKSA Innovations, Dr. Mary Pat Moyer will meet with fellow CEOs, leaders and directors of companies, innovative scientists and clinicians, investors, and economic development professionals interested in new company formation and growth or expansion of existing companies globally. Discussions and presentations will focus on […]

March 7, 2016 – San Antonio, TX USA. The Leadership Texas Class of 2016 has selected Dr. Mary Pat Moyer to be their honored guest at a recognition dinner as a “Luminary Woman of San Antonio.” Leadership Texas is highly competitive and the longest-running women’s leadership development program in the US. It is designed specifically […]

March 14-16, 2016 – San Antonio, TX USA. INCELL is a Sponsor of the 2016 national Parenteral Drug Association (PDA) meeting. INCELL will have a trade show booth with manufacturing and project managers on site to discuss manufacturing sterile fill and other products. INCELL scientists, Dr. Mary Pat Moyer, Vanessa Ramirez and George Plasko will participate […]

September 12-13, 2016 – Washington DC, USA. Dr. Mary Pat Moyer, INCELL CEO and Chief Science Officer, has been selected to speak in Session 1 at the US Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Public Hearing on Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or […]

April 15, 2016 – Dallas TX, USA. The FDA Medical Device Industry Coalition (FMDIC) is sponsoring its 2016 Big Event on the topic “Quality System Survival: Success Strategies for P&PC/CAPA.” fmdic.org/big-event-2016/ Dr. Mary Pat Moyer, FMDIC Member and INCELL CEO/CSO has been involved in the meeting planning and organization. Dr. Moyer and Lynn Miller, INCELL […]